Episode 13: Tachycardias and Tachyarrhythmias
In this episode, Dr. Purington, Dr. Louras and Dr. Ghafouri discuss prehospital management of undifferentiated tachyarrhythmias.
Reference:
Fernandez AR, Bourn SS, Duncan D, Slovis CM, Crowe RP, Treichel A, Myers JB. Comparing Prehospital Adenosine Initial Dosing of 6 mg Versus 12 mg for Presumed Paroxysmal Supraventricular Tachycardia (PSVT). Prehosp Emerg Care. 2025 Jun 5:1-6.
Fornage LB, O'Neil C, Dowker SR, Wanta ER, Lewis RS, Brown LH. Prehospital Intervention Improves Outcomes for Patients Presenting in Atrial Fibrillation with Rapid Ventricular Response. Prehosp Emerg Care. 2024;28(7):910-919.
Patrick C, Crowe RP, Ward B, Mohammed A, Keene KR, Dickson R. Feasibility of prehospital esmolol for refractory ventricular fibrillation. J Am Coll Emerg Physicians Open. 2022 Apr 9;3(2):e12700.
American Heart Association. (2020). Advanced Cardiovascular Life Support Provider Manual. American Heart Association.
American Heart Association. (2025). ACLS Guidelines Update: Adult Tachycardia With a Pulse. AHA Scientific Sessions.
National Association of EMS Physicians (NAEMSP). (2023). Model EMS Protocols: Cardiac Dysrhythmias.
Singh S, McKintosh R. Adenosine. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Smith, Jane D., and Robert T. Jones. “Management of Tachydysrhythmias.” Rosen’s Emergency Medicine: Concepts and Clinical Practice, edited by John A. Marx, Robert S. Hockberger, Ron M. Walls, Marianne Gausche-Hill, R. Brooke Jeffrey, and Scott R. Levin, 9th ed., Elsevier, 2018, pp. 1452–1478.
Page, R, Joglar, J, Caldwell, M. et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. JACC. 2016 Apr, 67 (13) e27–e115.
Joglar JA, Chung MK, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83(1):109-279.
Sarwar CM, Papadimitriou L, Pitt B, Piña I, Zannad F, Anker SD, Gheorghiade M, Butler J. Hyperkalemia in Heart Failure. J Am Coll Cardiol. 2016 Oct 4;68(14):1575-89.
Nasir M, Sturts A, Sturts A. Common Types of Supraventricular Tachycardia: Diagnosis and Management. Am Fam Physician. 2023 Jun;107(6):631-641.
Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998 Oct 16;82(8A):2N-9N.
Al-Khatib, S, Stevenson, W, Ackerman, M. et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. JACC. 2018 Oct, 72 (14) e91–e220.
Alpar S, Tatlıparmak AC. Evaluating smartwatch-based detection of supraventricular tachycardia and atrial fibrillation in the emergency department. Am J Emerg Med. 2025 Sep;95:101-106.
Nazarian S, Lam K, Darzi A, Ashrafian H. Diagnostic Accuracy of Smartwatches for the Detection of Cardiac Arrhythmia: Systematic Review and Meta-analysis. J Med Internet Res. 2021 Aug 27;23(8):e28974.
Spatz ES, Ginsburg GS, Rumsfeld JS, Turakhia MP. Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine. N Engl J Med. 2024 Jan 25;390(4):346-356.
Magliocca A, Fornari C, Fumagalli F, Merigo G, Rahimi M, Stirparo G, Coppo A, Migliari M, Grasselli G, Cheskes S, Ristagno G. Amplitude spectrum area to predict true shock-refractory ventricular fibrillation during basic life support-treated out-of-hospital cardiac arrest. Resuscitation. 2025 Oct;215:110695.